Stocks & ETFs Screener: 95 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
950B | 84.1% | 69.1% | 68.4% | 51.8 | 26.1% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Medical Devices |
489B | 80.0% | 64.0% | 61.1% | 19.6 | 20.5% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Respiratory |
281B | 79.5% | 41.5% | 49.9% | 30.1 | 13.4% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
275B | 83.5% | 38.9% | 75.4% | 29.5 | 24.2% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular,Oncology,Immunology,.. |
244B | 94.3% | 59.6% | 94.6% | 17.4 | 11.8% |
| MRK Merck |
Pharmaceuticals
Keytruda, Gardasil, Januvia |
237B | 85.2% | 63.2% | -0.50% | 12.6 | -9.14% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity Medication |
212B | 89.1% | 42.0% | -42.4% | 13.2 | -61.0% |
| PFE Pfizer |
Pharmaceuticals
Vaccines, Antivirals, Oncology |
139B | 63.9% | 67.8% | -36.4% | 14.2 | -8.77% |
| SAN Sanofi |
Pharmaceuticals
Immunology, Oncology, Neurology |
126B | 65.1% | 63.0% | -2.97% | 17.1 | -14.6% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Oncology, Immunology |
124B | 63.2% | 53.9% | 28.3% | 16.7 | -6.28% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Hematology, Immunology |
99.0B | 76.8% | 60.1% | -58.1% | 15.7 | -24.7% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
95.5B | 79.6% | 19.9% | 77.1% | 13.5 | 26.7% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
94.8B | 78.5% | 30.8% | 58.6% | 13.6 | 15.8% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Drugs, Pigments |
56.2B | 57.9% | 37.9% | -64.8% | 16.5 | -29.1% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
52.4B | 88.0% | 68.9% | -50.4% | 19.9 | -38.5% |
| TAK Takeda |
Pharmaceuticals
Gastroenterology, Oncology, Rare |
45.1B | 60.1% | 36.1% | 28.6% | 204 | -2.66% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
30.5B | 49.2% | 1.0% | 3.15% | - | 36.2% |
| TEVA Teva Pharma |
Pharmaceuticals
Generic Drugs, CNS Therapies |
27.8B | 54.6% | 17.8% | 72.2% | 39.7 | 31.0% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Rare Disease, Cancer |
22.7B | 54.9% | 71.5% | 29.5% | 22.2 | 36.0% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
12.5B | 89.0% | 49.6% | 47.3% | 24.5 | 2.48% |
| VTRS Viatris |
Pharmaceuticals
Brand, Generic, Biosimilar |
12.1B | 31.7% | 59.2% | -13.5% | - | -27.5% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.6B | 76.1% | 45.2% | 31.5% | 17.6 | -15.3% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.1B | 45.5% | - | 57.8% | 318 | 52.2% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
10.8B | 50.3% | - | 6.82% | - | 28.4% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
7.97B | 68.1% | - | 86.8% | 86.8 | 16.2% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
7.53B | 33.6% | - | 81.6% | - | 36.9% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.66B | 70.0% | - | 80.1% | - | 28.0% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.44B | 86.7% | 57.2% | 60.0% | 22.5 | -2.02% |
| TARS Tarsus |
Pharmaceuticals
Eyelash Mite Therapy, Ocular |
3.38B | 38.3% | - | 71.4% | - | 50.0% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
2.92B | 64.0% | 0.21% | -22.0% | 14.7 | -40.1% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.62B | 47.5% | - | 41.7% | - | 10.4% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.61B | 27.8% | - | 71.5% | - | 17.5% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.56B | 51.7% | 4.23% | -37.0% | 6.47 | -32.2% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
2.53B | 26.3% | - | 93.6% | - | 134% |
| TERN Terns |
Pharmaceuticals
TKI, THR-Agonist, GLP-1-Agonist |
2.35B | 32.7% | - | 60.7% | - | 328% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.26B | 63.8% | - | 79.5% | - | 80.3% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.09B | 74.1% | 49.8% | -36.1% | 16.9 | -16.1% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.98B | 61.0% | 51.0% | -85.9% | 3.94 | -60.5% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
1.96B | 91.7% | - | -38.4% | 10.7 | -10.3% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.79B | 68.4% | - | 92.9% | 49.8 | 21.9% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Precision Medicine, APOL1 |
1.74B | 24.1% | - | 91.1% | - | 106% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.74B | 44.4% | 74.1% | -78.5% | - | -58.8% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.69B | 62.0% | 36.6% | 82.4% | 24.9 | 60.5% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 86.5% | 2.39% | 63.7% | 13.4 | -2.06% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, Amx0035, Amx0114 |
1.61B | 21.4% | - | -5.22% | - | 131% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.46B | 22.8% | - | -81.1% | - | -49.9% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.44B | 44.5% | - | 61.8% | - | -18.1% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.43B | 81.7% | - | 78.0% | 27.7 | 30.7% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.37B | 30.8% | - | 92.0% | - | 245% |
| RAPP Rapport |
Pharmaceuticals
Antiepileptic, Analgesic |
1.30B | 31.3% | - | 45.8% | - | 12.0% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
1.29B | 28.3% | - | -3.82% | - | -22.8% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Treg Stimulator, PEG-CSF1, TNFR2 |
1.21B | 31.1% | - | 31.9% | - | 217% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.21B | 73.6% | - | -25.4% | 11.5 | -47.2% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
1.18B | 29.3% | - | 7.22% | - | -55.8% |
| TLRY Tilray |
Pharmaceuticals
Cannabis,Beverage,Wellness,Distribu.. |
1.16B | 44.3% | - | -59.0% | - | -40.0% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.14B | 46.1% | - | 42.5% | - | 8.25% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.13B | 62.5% | - | 86.1% | - | 102% |
| PHAT Phathom |
Pharmaceuticals
GERD,Heartburn,H.Pylori,Esophagitis |
1.07B | 65.8% | - | 42.8% | - | 43.9% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.02B | 61.8% | - | -33.0% | 50.6 | 17.4% |
| EYPT Eyepoint |
Pharmaceuticals
Therapeutics, Retinal, Durasert |
959M | 27.3% | - | 69.8% | - | 37.7% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Ampreloxetine |
936M | 51.7% | - | 67.1% | 32.4 | 72.5% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
908M | 48.4% | - | 0.64% | 21.6 | 1.13% |
| ARVN Arvinas |
Pharmaceuticals
PROTAC, Cancer, Breast, Prostate |
847M | 40.6% | - | -73.4% | - | -58.7% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
790M | 93.8% | - | 52.8% | 4.54 | -12.9% |
| AQST Aquestive |
Pharmaceuticals
Epinephrine Film, Apomorphine |
686M | 55.1% | - | 69.6% | - | 6.08% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
682M | 35.7% | - | -13.2% | - | 326% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
629M | 36.8% | - | 12.9% | - | -26.9% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
599M | 23.2% | - | 51.8% | - | 201% |
| NMRA Neumora |
Pharmaceuticals
Kappa Antagonist, Agitation Drug |
449M | 44.5% | - | -64.3% | - | -80.3% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
444M | 26.2% | - | -35.9% | - | -53.0% |
| ETON Eton |
Pharmaceuticals
Hormone, Enzyme, Metabolic |
437M | 56.2% | - | 77.7% | - | 16.3% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox, TPOXX, Health |
418M | 83.5% | 89.0% | 12.0% | 5.67 | -20.8% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Bipolar Depression, Major |
412M | 43.1% | - | -14.0% | - | 166% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Liquor, Pre-Rolls |
409M | 50.2% | - | -27.9% | - | -22.7% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
405M | 18.3% | - | -83.4% | - | -75.8% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
319M | 30.5% | - | -53.1% | - | -40.5% |
| RLMD Relmada |
Pharmaceuticals
Controlled-Release, Formulation |
313M | 45.0% | - | 13.5% | - | 37.5% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
310M | 51.6% | - | -45.6% | 0.64 | -57.7% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Obesity |
284M | 25.5% | - | -50.2% | - | -40.0% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
272M | 29.5% | - | -64.2% | - | -39.2% |
| TVRD Tvardi |
Pharmaceuticals
Oral, STAT3, Inhibitor, Phase-2 |
242M | 29.1% | - | -60.5% | - | -68.5% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading, Payments, Tokenization |
239M | 26.9% | 1.0% | -9.69% | - | -25.9% |
| ACB Aurora Cannabis |
Pharmaceuticals
Dried Cannabis, Cannabis Oil |
238M | 63.3% | - | -38.7% | - | -15.8% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
232M | 41.7% | - | -42.8% | - | -22.6% |
| MDWD Mediwound |
Pharmaceuticals
Eschar,Burn,Therapy,Tissue,Biopharm.. |
219M | 20.0% | - | 28.4% | - | -7.70% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis,Flower,Pre-Rolls,Vapes,Edi.. |
208M | 41.3% | - | -34.9% | 155 | -12.8% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
197M | 24.7% | - | -36.1% | - | 13.1% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
151M | 50.3% | - | 20.9% | - | 52.2% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 32.9% | 0.17% | -61.7% | - | -40.4% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Disease |
132M | 37.7% | - | -7.82% | - | 60.5% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
118M | 64.9% | - | -49.8% | - | -7.52% |
| TELO Telomir |
Pharmaceuticals
Small Molecule, Degenerative |
44.0M | 41.8% | - | -94.2% | - | -75.0% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual, Aspirin, Melatonin |
20.2M | 39.3% | - | -81.4% | - | -99.2% |
| CTXR Citius |
Pharmaceuticals
Immunotherapy, Antibiotic |
19.8M | 35.1% | - | -83.1% | - | -69.9% |
| ITRM Iterum Therapeutics |
Pharmaceuticals
Oral Penem, Intravenous Penem, UTI |
18.6M | 28.9% | - | -89.6% | - | -81.4% |